PRAGUE & BASEL, Switzerland & BOSTON–(BUSINESS WIRE)–SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today announced it will present new preclinical and translational data from multiple investigational programs at two scientific conferences in November – the World ADC Conference in San Diego, California, and PEGS Europe, in Lisbon, Portugal. At these global forums, SOTIO will highlight progress across its next-generation antibody-drug conjugates (ADCs) and immuno
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
